Recently, the Ptenm3m4 mouse model with germline expression of engineered, nuclear-excluded non-naturally occurring Pten mutations, has indicated a role for nuclear PTEN defects in driving neuronal and immune phenotypes in PHTS (Tilot et al., 2014; Jaini et al., 2020). Here, PTEN is linked to PTEN hamartoma tumor syndrome.